Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Allison C. Ortigosa
Introduction
Allison C. Ortigosa is a notable inventor based in Harrisonburg, Virginia. She has made significant contributions to the field of biochemistry, particularly in the development of insulin formulations. Her work has implications for diabetes treatment and management, showcasing her dedication to improving healthcare through innovation.
Latest Patents
Allison holds a patent for a "Method for preparing crystalline insulin or insulin analog compositions." This method involves crystallizing insulin or insulin analogs under alkaline conditions in the presence of zinc. The process includes purifying the crystals by filtering and drying them to produce crystalline insulin or insulin analog compositions. This method has been exemplified with insulin lispro, highlighting its practical application in the pharmaceutical industry.
Career Highlights
Allison is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. Her role at Merck allows her to collaborate with other experts in the field and contribute to groundbreaking research and development in insulin therapies.
Collaborations
Throughout her career, Allison has worked alongside esteemed colleagues such as Douglas S. Watson and Mark C. Sleevi. These collaborations have fostered an environment of innovation and have led to advancements in insulin formulation techniques.
Conclusion
Allison C. Ortigosa's contributions to the field of insulin research exemplify her commitment to enhancing diabetes treatment. Her innovative methods and collaborative spirit continue to influence the pharmaceutical industry positively.